Analytical Data
-
Gene name
SYNM
- Application
-
Alternative Names
Desmuslin
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O15061
-
Expression Region
1241-1565 aa
-
AA Sequence
SAAGKVGDYFATEESVGTQTSVRQLQLGPKEGFSGQIQFTAPLSDKVELGVIGDSVHMEGLPGSSTSIRHISIGPQRHQTTQQIVYHGLVPQLGESGDSESTVHGEGSADVHQATHSHTSGRQTVMTEKSTFQSVVSESPQEDSAEDTSGAEMTSGVSRSFRHIRLGPTETETSEHIAIRGPVSRTFVLAGSADSPELGKLADSSRTLRHIAPGPKETSFTFQMDVSNVEAIRSRTQEAGALGVSDRGSWRDADSRNDQAVGVSFKASAGEGDQAHREQGKEQAMFDKKVQLQRMVDQRSVISDEKKVALLYLDNEEEENDGHWF
-
Molecular Weight
42kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SYNM (Synaptopodin-2) is a protein that has gained significant attention in recent years due to its role in synaptic function and plasticity. Originally identified in neurons, SYNM is believed to play a crucial role in the development and maintenance of dendritic spines, which are essential for synaptic transmission and cognitive processes such as learning and memory. Recent studies have suggested that SYNM may be involved in various neurological disorders, including schizophrenia, autism spectrum disorders, and neurodegeneration, highlighting its potential as a therapeutic target. Researchers are increasingly focused on understanding the molecular mechanisms underlying SYNM's function, such as its interactions with other proteins and its regulatory pathways. Additionally, advances in protein engineering and expression systems have enabled the production of recombinant SYNM, facilitating in-depth studies of its structure and function. The exploration of SYNM recombinant proteins will not only enhance our understanding of synaptic dynamics but also provide insights into developing novel treatments for affective disorders and neurodevelopmental conditions.
